Skip to main content
MedPathMedPath Home
Clinical Trials/NCT01314664
NCT01314664
Terminated
Not Applicable

A PROSPECTIVE REGISTRY TO ASSESS THE EFFECTIVENESS AND LOCAL TOLERABILITY OF INTRAVESICAL VALRUBICIN IN SUBJECTS WITH NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC)

Endo Pharmaceuticals10 sites in 1 country15 target enrollmentMay 2011
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsBladder CancerCIS

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Bladder Cancer
Sponsor
Endo Pharmaceuticals
Enrollment
15
Locations
10
Status
Terminated
Last Updated
10 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSitesSimilar Trials

Overview

Brief Summary

The purpose of this study is to observe and describe the effectiveness and local tolerability of intravesical treatment with valrubicin for non-muscle invasive bladder cancer (NMIBC) in a cohort of subjects treated under routine practice conditions.

Registry
clinicaltrials.gov
Start Date
May 2011
End Date
January 2012
Last Updated
10 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Endo Pharmaceuticals
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • •Males and females 18 years of age and older
  • •Diagnosed with NMIBC
  • •Prescribed intravesical valrubicin to treat NMIBC
  • •Understood and signed Informed Consent to participate

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Study Sites (10)

Loading locations...

Similar Trials

Unknown
Not Applicable
Feasibility of M-health Version of "What Were We Thinking" Intervention to Promote Maternal Postpartum Mental HealthDepression, PostpartumAnxiety Disorders and SymptomsMaternal Behavior
NCT04847076Universidad del Desarrollo90
Withdrawn
Not Applicable
Observational Prospective Registry of the Efficacy, Safety, and Adherence to Infergen® in Patients Infected With Hep CHepatitis C
NCT00951223Kadmon Corporation, LLC
Completed
Not Applicable
Observational Study to Assess the Adequacy of Methadone Dosage, in Heroin Addicted Patients in a MMT.Heroin Addiction
NCT02062736L.Molteni & C. dei F.lli Alitti-Soc. di Esercizio S.p.A.500
Completed
Phase 1
Prospective study on the effectiveness assessment of Indocyanine Green Lymphography and Lymphatic Surgery for lymphedema and lymphatic disease.ymphedema and lymphatic disease, chylous thoracs and ascites
JPRN-UMIN000021762Saiseikai Kawaguchi General Hospital200
Completed
Phase 1
Prospective study on the effectiveness assessment of Indocyanine Green Lymphography and Lymphatic Surgery for lymphedema and lymphatic disease.ymphedema and lymphatic disease
JPRN-UMIN000022973Saiseikai Kawaguchi General Hospital. Department of lymphatic and reconstructive surgery.200